Vitamin cartel: Roche faces penalties

Several international pharmaceutical companies face the possibility of fines being levied on the price of vitamins. Basel's Roche, and Germany's BASF are on the list being drafted by Australia and Japan.

This content was published on July 29, 2000 - 07:50

The two countries are investigating the companies in order to establish whether they are monopolising the vitamin market.

Last year, Roche and BASF were condemned by the United States and Canada, and ordered to pay hundreds of millions of dollars in fines.

Rhone-Poulenc, the affiliate of the German-Swiss group Aventis, were also subject to stiff penalties.

At the beginning of July, several vitamin producers were warned by the European Commission against monopolising the vitamin market.

The companies have nine weeks to respond.

swissinfo with agencies

Articles in this story

This article was automatically imported from our old content management system. If you see any display errors, please let us know:

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?